Hospital Necker

Paris 75743

1 studies enrolling now · 6 studies all time

What they study most

Adult T-cell Leukemia-Lymphoma, Atopic Dermatitis, COVID-19, MPS IVA, Morquio A Syndrome, Mucopolysaccharidosis IV Type A, Multiple Myeloma, Sickle Cell Disease

Studies at this site

• Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy — Enrolling by invitation
• A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19 — Completed
• KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) — Completed
• A Multicenter, Multinational, Observational Morquio A Registry Study (MARS) — Completed
• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis — Stopped early
• Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma — Completed